You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cancer immunotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Profiling for Cancer Immunotherapy Response

Recruiting
  • Cancer
  • +3 more
  • Methylation Cytometry
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Nov 6, 2023

Physical Activity and Exercise in Cancer Immunotherapy Treatment

Not yet recruiting
  • Cancer
  • Physical Activity and Exercise in Cancer Immunotherapy Treatment - Exploratory study of experiences and perceptions
  • (no location specified)
Nov 22, 2023

Prognosis of Lung Cancer Immunotherapy

Not yet recruiting
  • Lung Cancer
    • (no location specified)
    May 31, 2023

    Cancer, Immune-related Adverse Event Trial in Durham (Medical chart review)

    Enrolling by invitation
    • Cancer
    • Immune-related Adverse Event
    • Medical chart review
    • Durham, North Carolina
      Duke University Medical Center
    Oct 20, 2023

    Tumor and Peripheral Blood to Evaluate Efficacy of Cancer

    Recruiting
    • Lung Cancer
    • Esophageal Cancer
    • In vitro stimulation of Pbmc with tumor antigen nanoparticles
    • Suzhou, Jiangsu, China
      The first affiliated hospital of soochow university
    Mar 16, 2023

    Gynecologic Cancer, Cervical Cancer, Endometrial Cancer Trial in Taoyuan City (Hyperpolarized 13C-Pyruvate injection)

    Not yet recruiting
    • Gynecologic Cancer
    • +3 more
    • Hyperpolarized 13C-Pyruvate injection
    • Taoyuan City, Guishan District, Taiwan
      Chang Gung Memorial Hospital
    Apr 5, 2023

    TRAQinform Assessment of Immunotherapy Response

    Not yet recruiting
    • Melanoma
    • Non-Interventional
    • (no location specified)
    Apr 6, 2023

    Opportunistic Autoimmune Diseases Trial in Strasbourg (Biological collection)

    Recruiting
    • Opportunistic Autoimmune Diseases
    • Biological collection
    • Strasbourg, Alsace, France
      Hopitaux universitaires de strasbourg
    Aug 17, 2022

    Triple Negative Breast Cancer Trial in Birmingham ([18F]FMISO-PET with contrast-enhanced MRI)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • [18F]FMISO-PET with contrast-enhanced MRI
    • Birmingham, Alabama
      UAB
    Nov 15, 2022

    Elderly Patients, Metastatic Lung Cancer Trial in Wuhan (Single drug chemo plus immunotherapy)

    Not yet recruiting
    • Elderly Patients
    • Metastatic Lung Cancer
    • Single drug chemotherapy plus immunotherapy
    • Wuhan, Hubei, China
      Hubei Cancer Hospital
    Sep 15, 2023

    GI Complications in Cancer Immunotherapy Patients

    Recruiting
    • Malignant Melanoma
      • Boston, Massachusetts
        Massachusetts General Hospital
      Apr 4, 2022

      Multidimensional Aspects of QUAlity of Life After Cancer

      Recruiting
      • Solid Tumor
      • Hematologic Cancer
      • QoL & irAEs determinants
      • Pierre-Bénite, France
      • +4 more
      Nov 15, 2022

      Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

      Not yet recruiting
      • Cervical Cancer
      • Anti-PD-1 antibody balstilimab
      • Amsterdam, Netherlands
        Amsterdam UMC
      Oct 17, 2023

      Non Small Cell Lung Cancer, Locally Advanced, Radiotherapy Trial in Wuhan (CTV omitted or delineated)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • CTV omitted or delineated
      • Wuhan, Hubei, China
        Hubei Cancer Hospital
      Sep 1, 2023

      Solid Cancers Trial in Toulouse (Patients treated with immune checkpoint blockade)

      Recruiting
      • Solid Cancers
      • Patients treated with immune checkpoint blockade
      • Toulouse, France
      • +1 more
      Mar 28, 2022

      Castration Resistant Prostate Cancer, CRPC Trial in Seoul (Cellgram-DC-PC)

      Terminated
      • Castration Resistant Prostate Cancer, CRPC
      • Cellgram-DC-PC
      • Seoul, Korea, Republic of
        Asan medical center
      Dec 29, 2022

      Advanced Ovarian Cancer Trial in Guangzhou (Plasmodium immunotherapy)

      Not yet recruiting
      • Advanced Ovarian Cancer
      • Plasmodium immunotherapy
      • Guangzhou, Guangdong, China
        The Third Affiliated Hospital of Southern Medical University
      Jul 5, 2023

      Ovarian Cancer Trial in Seoul (Cellgram-DC)

      Terminated
      • Ovarian Cancer
      • Cellgram-DC
      • Seoul, Korea, Republic of
        Asan medical center
      Dec 29, 2022

      Stage II-III Breast Cancer Trial in Shenyang (cytotoxic chemo (docetaxel or epirubicin or cyclophosphamide or carboplatin),

      Recruiting
      • Stage II-III Breast Cancer
      • cytotoxic chemotherapy (docetaxel or epirubicin or cyclophosphamide or carboplatin)
      • +2 more
      • Shenyang, Liaoning, China
      • +1 more
      Aug 3, 2022

      Integrative Multi-Omics Testing for Immunotherapy Response in

      Recruiting
      • Lung Cancer
        • Guangzhou, Guangdong, China
          Nanfang hospital
        Jun 29, 2023

        Radiotherapy, Immunotherapy, Liver Metastases Trial in Shanghai (SBRT, Chemotherapy, PD-1 antibody)

        Recruiting
        • Radiotherapy
        • +3 more
        • SBRT
        • +2 more
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 2, 2023

        Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H

        Recruiting
        • Colorectal Cancer
          • Shanghai, China
            Fudan University Shanghai Cancer Center
          Oct 18, 2023

          Liver Cancer Trial in Wuhan (Autologous Tumor Infiltrating Lymphocytes)

          Recruiting
          • Liver Cancer
          • Autologous Tumor Infiltrating Lymphocytes
          • Wuhan, China
            Tongji Hospital
          Oct 9, 2023

          Advanced Non-Small Cell Squamous Lung Cancer, Radiotherapy, Immunotherapy Trial in Wuhan (CTV omitted or delineated)

          Not yet recruiting
          • Advanced Non-Small Cell Squamous Lung Cancer
          • +2 more
          • CTV omitted or delineated
          • Wuhan, Hubei, China
            Hubei Cancer Hospital
          Sep 7, 2023

          Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

          Recruiting
          • Lung Cancer
            • Shanghai, China
              Shanghai Chest Hospital
            Jul 20, 2023